We found that the number of colonic tumors and the size of B16-OVA tumors in IL-37 absent and present mice when injected with IL-18-blocking antibodies was not significantly differences (Fig. 5a, b and Supplementary Fig. S7b). This evidence concerns the gene IL37 and colonic neoplasm.